Navigation Links
MichBio Responds to Governor's Plan to Repeal Tort Reform Laws
Date:1/30/2008

ANN ARBOR, Mich., Jan. 30 /PRNewswire-USNewswire/ -- In a letter to Governor Jennifer Granholm today, MichBio Executive Director, Stephen Rapundalo, Ph.D., responded to the Governor's State of the State Address wherein she called for a repeal of current tort laws. MichBio is the statewide association for Michigan's life sciences industry.

"MichBio lauds your efforts, and those of the legislature, to diversify the state's economy by focusing on high technology areas like life sciences," said Rapundalo, writing on behalf of MichBio's more than 230 members. "However, a repeal of existing tort laws would be a detriment to the life sciences industry, would reverse 10 years of steady growth, neuter the economic development impact of the 21st Century Jobs Fund, and without a doubt diminish future investments in this market sector."

Rapundalo indicated that biotechnology and life science companies face many difficult challenges, a risk-averse investor climate, and lengthy and costly research and development timelines.

"Reversing current law would send a strong message that Michigan is not open for business, forcing new and existing biotech companies to look elsewhere to invest. Companies will not pursue their R&D plans with the knowledge or potential for litigation waiting for them at the end of their commercialization pathway. Repeal will result in a loss of current Michigan jobs and discourage any future biotech business investments and job creation in Michigan."

Noting that drugs and medical devices are the most regulated products around, Rapundalo said, "Less than 1/100 of a percent of potential medications investigated survives the FDA regulatory review gauntlet and become product launches. The contention that lay juries with no medical or science training, or understanding of the new drug application process, are better judges of relatively brief testimony, as opposed to the 12-18 month exhaustive review by experts in the field, is irresponsible. The tort system is simply ill-suited to reach a better conclusion than the FDA on drug or medical device safety.

"So let's leave product liability to the experts, and leave the tort system as is. Current law and process present an appropriate balance whereby the FDA is allowed to perform its regulatory duties, but allowing for punishment of companies that willfully withhold information or interfere with the drug approval process. Let's not unduly raise the risks for the many due to failures of the few, where current law and tort reform already provides for meaningful recourse to the injured. Michigan residents are already more than adequately protected."

Rapundalo said the issue of tort reform may be politically expedient, but it is not a benefit in practical terms. "We have made so much progress in Michigan, especially in the face of difficult economic times. I know the state would like to see the growth in the life sciences community continue, but changing these laws could do irreparable harm to all of the progress that we have made. The proposed repeal is simply at odds with our state's economic development strategy at a time when we can least afford further losses in the life sciences industry."

MichBio is committed to driving the growth of Michigan's life science industry and to fostering the collective impact of its members by serving as their unified voice and by providing them with education, information, connections and other services. MichBio members include life sciences companies, academic and research institutions, bioscience service providers, and related organizations.


'/>"/>
SOURCE MichBio
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. MichBio Expo Opens in Lansing Next Week
2. MichBio Announces Student Career Day at Michigan State University
3. MichBio Issues 2007/8 Michigan Life Sciences Directory and Resources Guide
4. MichBio Announces Expo Tours; Extends Deadline for Innovator Showcase Applications
5. Michigan Life Sciences Pipeline to Kick Off MichBio Expo
6. CellCyte Genetics Corp. Responds to Plaintiff Law Firm Press Releases
7. Bio-Identical Hormone Menopause Doctor Responds to Recent FDA News About Estriol
8. Bio-Identical Hormone Menopause Doctor Responds to Outrageous FDA News
9. CryoLife Responds to Inaccurate Assertions from Plaintiffs Attorney
10. GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
11. Michigan Catholic Conference Responds to Formation of Embryonic Stem Cell Research Ballot Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)... Lexington, Massachusetts (PRWEB) , ... May 17, 2017 ... ... software company specializing in medical device compliance and commercialization, has just released version ... lot of work into this latest version of Cockpit,” says David Cronin, CEO ...
(Date:5/18/2017)... ... May 17, 2017 , ... HOLLOWAY AMERICA, ... including food and dairy, munitions, and pharmaceutical/biotech, recently introduced The Revolution Lift™, a ... use. The improvement in technology comes on the heels of HOLLOWAY’s release of ...
(Date:5/18/2017)... , ... May 17, 2017 , ... ... for example, are more likely to develop Alzheimer’s disease, while men are at ... account for this gender-specific neuronal bias is the aim of a research program ...
(Date:5/16/2017)... , ... May 16, 2017 , ... ... announced its global Genedata Screener User Group Meetings, which will be ... the opportunity to share best practices in screening data analysis and learn about ...
Breaking Biology Technology:
(Date:4/19/2017)... York , April 19, 2017 ... as its vendor landscape is marked by the presence ... market is however held by five major players - ... Together these companies accounted for nearly 61% of the ... the leading companies in the global military biometrics market ...
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, a ... authentication solutions, today announced that it has been ... Research Projects Activity (IARPA) to develop next-generation Presentation ... "Innovation has been a driving force ... program will allow us to innovate and develop ...
(Date:4/5/2017)...  The Allen Institute for Cell Science today announces ... portal and dynamic digital window into the human cell. ... application of deep learning to create predictive models of ... a growing suite of powerful tools. The Allen Cell ... publicly available resources created and shared by the Allen ...
Breaking Biology News(10 mins):